• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro ' by Agca .

作者信息

Fornaro Marco, Cacciapaglia Fabio, Venerito Vincenzo, Lopalco Giuseppe, Iannone Florenzo

机构信息

Rheumatology Unit - Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy

Rheumatology Unit - Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.

出版信息

Ann Rheum Dis. 2020 Sep;79(9):e106. doi: 10.1136/annrheumdis-2019-216407. Epub 2019 Oct 11.

DOI:10.1136/annrheumdis-2019-216407
PMID:31604705
Abstract
摘要

相似文献

1
Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro ' by Agca .对阿格查（Agca）所著《对福纳罗（Fornaro）的<类风湿关节炎患者中胆固醇水平变化和疾病活动对不同算法估算的10年心血管风险的影响>的回应》的回应
Ann Rheum Dis. 2020 Sep;79(9):e106. doi: 10.1136/annrheumdis-2019-216407. Epub 2019 Oct 11.
2
Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro .对Fornaro所著《类风湿关节炎患者胆固醇水平变化和疾病活动对不同算法估算的10年心血管风险的影响》的回应
Ann Rheum Dis. 2020 Sep;79(9):e105. doi: 10.1136/annrheumdis-2019-215748. Epub 2019 Aug 14.
3
Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka ' by Berkhout .对Berkhout对Tanaka的《类风湿关节炎患者缓解后采用递增剂量策略持续停用英夫利昔单抗：RRRR研究，一项随机对照试验》的评论的回应
Ann Rheum Dis. 2021 Nov;80(11):e173. doi: 10.1136/annrheumdis-2019-216593. Epub 2019 Dec 9.
4
Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients.类风湿关节炎患者中胆固醇水平变化和疾病活动对采用不同算法估算的10年心血管风险的影响。
Ann Rheum Dis. 2020 Sep;79(9):e104. doi: 10.1136/annrheumdis-2019-215715. Epub 2019 May 29.
5
Do DMARDs and biologic agents protect from cardiovascular disease in patients with inflammatory arthropathies?抗风湿药物和生物制剂能否预防炎症性关节病患者的心血管疾病？
Autoimmun Rev. 2019 Dec;18(12):102401. doi: 10.1016/j.autrev.2019.102401. Epub 2019 Oct 23.
6
Cardiovascular Risk Assessment and Therapeutic Implications in Rheumatoid Arthritis.类风湿关节炎的心血管风险评估与治疗意义。
J Cardiovasc Transl Res. 2020 Oct;13(5):878-890. doi: 10.1007/s12265-020-09964-9. Epub 2020 Feb 20.
7
Increased lipid levels but unchanged atherogenic index in rheumatoid arthritis patients treated with biologic disease modifying antirheumatic drugs: published experience.使用生物性改善病情抗风湿药物治疗的类风湿关节炎患者血脂水平升高但动脉粥样硬化指数未变：已发表的经验
Clin Exp Rheumatol. 2009 May-Jun;27(3):446-51.
8
Cardiovascular risk estimation with 5 different algorithms before and after 5 years of bDMARD treatment in rheumatoid arthritis.类风湿关节炎患者接受生物改善病情抗风湿药（bDMARD）治疗5年前后，采用5种不同算法进行心血管风险评估。
Eur J Clin Invest. 2020 Dec;50(12):e13343. doi: 10.1111/eci.13343. Epub 2020 Jul 31.
9
Lipid paradox in rheumatoid arthritis: changes with rheumatoid arthritis therapies.类风湿关节炎中的脂质悖论：与类风湿关节炎治疗相关的变化。
Curr Rheumatol Rep. 2012 Oct;14(5):428-37. doi: 10.1007/s11926-012-0269-z.
10
Early, structured disease modifying anti-rheumatic drug (DMARD) therapy reduces cardiovascular risk in rheumatoid arthritis--a single centre study using non-biologic drugs.早期、规范化的改善病情抗风湿药物（DMARD）治疗可降低类风湿关节炎患者的心血管风险——一项使用非生物制剂药物的单中心研究
J Assoc Physicians India. 2013 Aug;61(8):531-4.